GLOBAL LIFE TECHNOLOGIES

CURA STRATEGIES representing GLOBAL LIFE TECHNOLOGIES · Q1 2026 · $10,000 · view on lda.senate.gov ↗

Issues lobbied

Key facts

Filing UUID
3f4cd51f-cc44-4200-876e-445b1ae5753d
Filing type
Q1
Filing period
first_quarter
Filing year
2026
Posted
2026-05-09T12:09:06-04:00
Registrant (lobbyist)
CURA STRATEGIES
Client
GLOBAL LIFE TECHNOLOGIES
Client location
MD / US
Client description
​Global Life Technologies is the maker of Nozin, a nasal sanitization product
Income reported
$10,000
Expenses reported
—